185821 - How to Treat quiz: NOACs in non-valvular atrial fibrillation
- : Online
How to Treat quiz: NOACs in non-valvular atrial fibrillationRelevance to General Practice
All NOACs available in Australia appear to be generally safe and effective alternatives to warfarin. ‘Real-world’ data suggest no significant differences for ischaemic stroke between NOACs and warfarin. NOACs seem to confer a risk reduction in prevention of haemorrhagic stroke, a serious complication of oral anticoagulation use.
Based on ‘real-world’ evidence, it appears that among patients treated with standard-dose NOAC for NVAF, dabigatran and apixaban generally appear to have a more favorable benefit-harm profile than rivaroxaban.
Anticoagulants do not create bleeds but increase the intensity of bleeding. Using specific reversal agents (for example, idarucizumab) is not a guarantee for improved clinical outcomes as it does not address the underlying cause of bleeding.
D1. Communication skills and the patient-doctor relationship
Ways in which health can be optimised and maintained are communicated to patients, family members and carers
D2. Applied professional knowledge and skills
Rational prescribing and medication monitoring is undertaken
D3. Population health and the context of general practice
D4. Professional and ethical role
D5. Organisational and legal dimensionsCurriculum Contextual Units
- Adult health